The association between KRAS (KRAS Proto-Oncogene, GTPase) and Cardiofaciocutaneous Syndrome 1 is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.
Sources2
Clinical variants24
Symptoms133
Compounds0
Trials0
Publications19
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.